Keywords: فلوتیکازون پروپیونات; dry powder inhaler (DPI); force control agent (FCA); blending method; dispersibility; next generation impactor (NGI); single particle aerosol mass spectrometry (SPAMS); time-of-flight secondary ion mass spectrometry (ToF-SIMS); AFM; atomic force microscop
مقالات ISI فلوتیکازون پروپیونات (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Salmeterol; Unit-dose inhaler; Multi-dose inhaler; Asthma; Non-inferiority;
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Salmeterol xinafoate; Dry powder inhaler; Leucine; Spray drying;
Keywords: فلوتیکازون پروپیونات; Childhood asthma; Efficacy; Omalizumab; Safety evaluation; Total IgE; AEs; adverse events; ER; emergency room; EOT; end of the treatment period; ELISA; enzyme-linked immunosorbent assay; FP; fluticasone propionate; FEV1; forced expiratory volume in 1Â s;
Keywords: فلوتیکازون پروپیونات; Severe asthma; Severe recurrent wheeze phenotypes; Children; Bacterial infection; Gastroesophageal reflux; Multiple allergies; BMI; Body mass index; FP; Fluticasone propionate; GERD; Gastroesophageal reflux; ICS; Inhaled corticosteroid; LTRA; Leukotriene
Keywords: فلوتیکازون پروپیونات; Steroid response; asthma; fluticasone; genome-wide association studies; inhaled corticosteroids; pharmacogenetics; 1000G; 1000 Genomes Project; FF; Fluticasone furoate; FP; Fluticasone propionate; GWAS; Genome-wide association study; ICS; Inhaled corticos
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Degradation rate; Degradation products; Chemical structure; Alkaline solution;
Keywords: فلوتیکازون پروپیونات; CSE; Cigarette smoke extracts; FP; Fluticasone propionate; FO; Formoterol fumarate dehydrate; GR; Glucocorticoid receptor; NF-κB; Nuclear factor-κB; ERK; Extracellular signal-regulated kinase1/2; HDAC2; Histone deacetylase 2; HDAC3; Histone deacetylase
Keywords: فلوتیکازون پروپیونات; ACTH; Adrenocorticotropin hormone; AI; Adrenal insufficiency; BMI; Body mass index; EoE; Eosinophilic esophagitis; FP; Fluticasone propionate; H-P-A; Hypothalamic-pituitary-adrenal; LDST; Low-dose stimulation test;
Keywords: فلوتیکازون پروپیونات; Azelastine hydrochloride; Fluticasone propionate; Direct spectrophotometry; Derivative of double divisor of ratio spectra; Mean centering
Keywords: فلوتیکازون پروپیونات; Asma; Broncodilatador; Fluticasona propionato; Formoterol fumarato; Glucocorticoides inhalados; Agonista β2-adrenérgico de acción largaAsthma; Bronchodilator; Fluticasone propionate; Formoterol fumarate; Inhaled corticosteroid; Long-acting β2-agonist
Keywords: فلوتیکازون پروپیونات; ICS; inhaled corticosteroid; Cys-LTs; cysteinyl leukotrienes; EBC; exhaled breath condensate; PEF; peak expiratory flow rate; FEV1; forced expiratory volume in first second; ELISA; enzyme linked immunoassay; FP; fluticasone propionate; P; oral prednisone;
Keywords: فلوتیکازون پروپیونات; AHR; airway hyperresponsiveness; ACQ; Asthma Control Questionnaire; ACOS; asthma-COPD overlap syndrome; BAL; bronchoalveolar lavage; CLCA1; chloride channel regulator 1; COPD; chronic obstructive lung disease; CS; corticosteroids; CXCR; CXC chemokine rece
Keywords: فلوتیکازون پروپیونات; Allergic rhinitis; tight junctions; fluticasone propionate; IL-4; leak pathway; epithelial resistance; epithelial permeability; ALI; Air-liquid interface; AR; Allergic rhinitis; FD4; Fluorescein isothiocyanate-dextran 4Â kDa; FP; Fluticasone propionate;
Keywords: فلوتیکازون پروپیونات; Asthma; Combination therapy; Fluticasone propionate; Formoterol; Single inhaler; Control
Keywords: فلوتیکازون پروپیونات; Asthma; Inhaled treatment; Corticosteroid; Fluticasone propionate; Formoterol fumarate
Keywords: فلوتیکازون پروپیونات; Asthma; Fluticasone propionate; Formoterol fumarate; Dose-response; Symptoms; Exacerbations;
Keywords: فلوتیکازون پروپیونات; Lipid; Nanocarriers; Fluticasone propionate; Nebulization; Drug delivery system; Aerosol; Inhalation
Keywords: فلوتیکازون پروپیونات; Asthma; Combination therapy; Efficacy; Fluticasone propionate; Formoterol fumarate;
Keywords: فلوتیکازون پروپیونات; Eosinophilic esophagitis; Corticosteroids; Fluticasone propionate; BudesonideEsofagitis eosinofílica; Corticoides; Fluticasona; Budesonida
Keywords: فلوتیکازون پروپیونات; Pregnancy; Asthma; Anti-asthmatic agents; Congenital abnormalities; Electronic medical records; Teratogens; BDP; Beclometasone dipropionate; CPRD; Clinical Practice Research Datalink; FP; Fluticasone propionate; FSC; Fluticasone propionate in fixed dose c
Keywords: فلوتیکازون پروپیونات; Dry powder inhaler; Carrier; Porosity; Pore size distribution; Surface roughness; Surface rugosity; Fines; Mercury intrusion porosimetry; Air permeability; Fluidization; Aerolizer; Fluticasone propionate;
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate/salmeterol combination; Fluticasone propionate; Asthma exacerbation; Human rhinovirus; Upper respiratory tract infection; AE; adverse event; C-ACT; Childhood Asthma Control Test; ER; emergency room; FP/SAL; fluticasone propionate/sa
Keywords: فلوتیکازون پروپیونات; Treatment; Inflammation; Dysphagia; Steroids; AE; adverse event; BMI; body mass index; CCHMC; Cincinnati Children's Hospital Medical Center; CFR; Code of Federal Regulations; CR; complete remission; EDP; Eosinophilic Esophagitis Diagnostic Panel; EoE; eos
Keywords: فلوتیکازون پروپیونات; CAlvNO; alveolar NO concentration; DPI; dry-powder inhaler; dN2; slope of single nitrogen washout curve; eNO; exhaled nitric oxide; FENO; fractional exhaled nitric oxide; FP; fluticasone propionate; ICS; inhaled corticosteroid; ppb; parts per billion; SFC
Keywords: فلوتیکازون پروپیونات; Montelukast; smoking; fluticasone propionate; leukotriene receptor antagonist; asthma control; corticosteroids; AE; Adverse experience; COPD; Chronic obstructive pulmonary disease; FVC; Forced vital capacity; PEF; Peak expiratory flow; SABA; Short-acting
Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial
Keywords: فلوتیکازون پروپیونات; Atopic dermatitis; Fluticasone propionate; Intermittent dosing; Prevention; Clinical trial;
Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management
Keywords: فلوتیکازون پروپیونات; Eosinophilic esophagitis; Eosinophilic gastrointestinal disease; APT; Atopy patch test; BET; Budesonide effervescent tablet; EC; eosinophilic colitis; EG; Eosinophilic gastritis; EGE; Eosinophilic gastroenteritis; EGID; Eosinophilic gastrointestinal disea
Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber
Keywords: فلوتیکازون پروپیونات; Allergic rhinitis; Azelastine; Environmental exposure chamber; Fluticasone propionate; Loratadine; Onset of action; AEC; Allergen exposure chamber; AR; Allergic rhinitis; EEC; Environmental exposure chamber; ePDAT; electronic Patient Data Acquisition Tabl
Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Formoterol fumarate; Scintigraphy; Deposition; Radiolabelled;
Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial
Keywords: فلوتیکازون پروپیونات; Asthma; Formoterol fumarate; Budesonide; Fluticasone propionate; Combination therapy; Inhaled corticosteroid;
Simultaneous analysis of glucocorticosteroid fluticasone propionate and its metabolite fluticasone propionate 17β-carboxylic acid in human plasma by UPLC-MS/MS at sub pg/mL level
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Fluticasone propionate 17β-carboxylic acid; UPLC-MS/MS; Sub pg/mL; Human plasma; Nasal spray;
Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy
Keywords: فلوتیکازون پروپیونات; Asthma; Chronic obstructive pulmonary disease; Combination therapy; Fluticasone propionate; Persistence; Retrospective analysis; Salmeterol; COPD; Chronic obstructive pulmonary disease; ISPOR; The International Society for Pharmacoeconomics and Outcomes R
Optimal step-down approach for pediatric asthma controlled by salmeterol/fluticasone: A randomized, controlled trial (OSCAR study)
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Moderate to severe asthma; Pediatric asthma; Salmeterol/fluticasone combination therapy; Step-down approachICS, inhaled corticosteroids; SFC, salmeterol/fluticasone combination therapy; FP, fluticasone propionate; FeNO, exhaled nit
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Salmeterol; Unit-dose inhaler; Multi-dose inhaler; Asthma; Non-inferiority
Effects of low- versus high-dose fluticasone propionate/formoterol fumarate combination therapy on AMP challenge in asthmatic patients: A double-blind, randomised clinical trial
Keywords: فلوتیکازون پروپیونات; Asthma; Fluticasone propionate; Formoterol fumarate; ICS/LABA; AMP bronchoprovocation test; Dose-response
Rhinite allergique : Dymista®, une alternative thérapeutique
Keywords: فلوتیکازون پروپیونات; Rhinite allergique; Alternative thérapeutique; Spray nasal; Chlorhydrate d'azélastine; Propionate de fluticasone; Association; Efficacité; Allergic rhinitis; Therapeutic alternative; Nasal sprays; Azelastine hydrochloride; Fluticasone propionate; Eff
Mechanisms of allergy and clinical immunologyAirway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma
Keywords: فلوتیکازون پروپیونات; Childhood asthma; inflammation/resolution; induced sputum; lipoxin A4; formyl peptide receptor 2-lipoxin receptor; glucocorticosteroids; ATS; American Thoracic Society; ERS; European Respiratory Society; FP; Fluticasone propionate; FPR2/ALXR; Formyl pep
Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?
Keywords: فلوتیکازون پروپیونات; Allergic rhinitis; Oral antihistamine; Intranasal antihistamine; Intranasal corticosteroid; Leukotriene receptor antagonist; Minimal clinically important difference (MCID); Seasonal allergic rhinitis (SAR); Total nasal symptom score (TNSS); AHRQ; Agency f
An inclusion complex of fluticasone propionate with γ-cyclodextrin in aqueous solution and in a solid state
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Dissolution rate; Inclusion complex; γ-Cyclodextrin; Solubility; Phase solubility diagram; Powder X-ray diffractometry
Fluticasone furoate/vilanterol 200/25Â mcg in Asian asthma patients: A randomized trial
Keywords: فلوتیکازون پروپیونات; Inhaled corticosteroid; Long-acting beta-agonist; Active-control; Efficacy; Safety; Fluticasone propionate;
Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
Keywords: فلوتیکازون پروپیونات; COPD; Fluticasone propionate; Salmeterol; Umeclidinium; Vilanterol;
Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD
Keywords: فلوتیکازون پروپیونات; Adenosine 5′-monophosphate; Airway hyperresponsiveness; Asthma; COPD; Fluticasone propionate
Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler
Keywords: فلوتیکازون پروپیونات; Fluticasone propionate; Salmeterol; Dry powder inhaler; Rotacaps; Rotahaler; Diskus
Efficacy and safety of umeclidinium/vilanterol 62.5/25Â mcg and tiotropium 18Â mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
Keywords: فلوتیکازون پروپیونات; Long-acting bronchodilator; Umeclidinium; Vilanterol; AE; adverse event; CI; confidence interval; COPD; chronic obstructive pulmonary disease; DPI; Dry powder inhaler; FEV1; forced expiratory volume in one second; FP; fluticasone propionate; FVC; forced v
Mechanisms of allergy and clinical immunologyInhaled long-acting β2 agonists enhance glucocorticoid receptor nuclear translocation and efficacy in sputum macrophages in COPD
Keywords: فلوتیکازون پروپیونات; Long-acting β2 agonist; corticosteroid; glucocorticoid receptor; sputum; COPD; macrophage; COPD; Chronic obstructive pulmonary disease; FP; Fluticasone propionate; GR; Glucocorticoid receptor; GRE; Glucocorticoid response element; ICS; Inhaled corticoste
Bone mineral density and associated parameters in pre-pubertal children with asthma treated with long-term fluticasone propionate
Keywords: فلوتیکازون پروپیونات; Asthma; Bone mineral density; Children; Fluticasone propionate
Simultaneous determination of montelukast as sparing therapy with some inhaled corticosteroids in plasma of asthmatic patients
Keywords: فلوتیکازون پروپیونات; Montelukast; Inhaled corticosteroids; Steroid-sparing therapy; Fluticasone propionate; Beclomethasone dipropionate; Budesonide;
Comparison of Mometasone Furoate Monohydrate (Nasonex) and Fluticasone Propionate (Flixonase) Nasal Sprays in the Treatment of Dust Mite-sensitive Children with Perennial Allergic Rhinitis
Keywords: فلوتیکازون پروپیونات; allergic rhinitis; eosinophil; fluticasone propionate; mometasone furoate monohydrate; nasal peak expiratory flow rate; Pediatric Rhinoconjunctivitis Quality of Life Questionnaire; total symptom score
Fluticasone Propionate Pharmacogenetics: CYP3A4*22 Polymorphism and Pediatric Asthma Control
Keywords: فلوتیکازون پروپیونات; FP; Fluticasone propionate; HWE; Hardy-Weinberg equilibrium; SNP; Single nucleotide polymorphism;